Growth Metrics

Corcept Therapeutics (CORT) Gains from Investment Securities (2010 - 2026)

Corcept Therapeutics recorded quarterly Gains from Investment Securities of $5.8 million in Q1 2026, up 124.58% quarter-over-quarter from -$23.4 million in Q4 2025, and down 63.6% year-over-year from $15.8 million in Q1 2025.

Corcept Therapeutics' Gains from Investment Securities history runs 16 years deep, the most recent figure standing at $5.8 million for Q1 2026.

  • In Q1 2026, Gains from Investment Securities fell 63.6% year-over-year to $5.8 million; the TTM figure through Mar 2026 stood at -$6.1 million (down 117.8% YoY), while the FY2025 annual figure was $13.0 million, down 41.85% from the prior year.
  • Gains from Investment Securities came in at $5.8 million for Q1 2026 at Corcept Therapeutics, up from -$23.4 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $39.5 million in Q4 2023 to a low of -$23.4 million in Q4 2025.
  • A 5-year average of $5.7 million and a median of $4.0 million in 2025 frame the typical range for Gains from Investment Securities.
  • Across the five-year window, Gains from Investment Securities surged 4567.97% in 2023 and plunged 435.49% in 2025, its largest moves.
  • Corcept Therapeutics' Gains from Investment Securities stood at $846000.0 in 2022, then soared by 4567.97% to $39.5 million in 2023, then tumbled by 82.31% to $7.0 million in 2024, then slumped by 435.49% to -$23.4 million in 2025, then soared by 124.58% to $5.8 million in 2026.
  • According to Business Quant data, Gains from Investment Securities over the past three periods registered $5.8 million, -$23.4 million, and $4.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Corcept Therapeutics 7.26 Bn 6.92 Bn 162.02 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 5.76 Mn
Mar 31, 2026 5.76 Mn
Dec 31, 2025 -23.43 Mn
Dec 31, 2025 -23.43 Mn
Sep 30, 2025 4.00 Mn
Sep 30, 2025 4.00 Mn
Jun 30, 2025 7.60 Mn
Jun 30, 2025 7.60 Mn
Mar 31, 2025 15.83 Mn
Mar 31, 2025 15.83 Mn
Dec 31, 2024 6.99 Mn
Dec 31, 2024 6.99 Mn
Sep 30, 2024 10.50 Mn
Sep 30, 2024 10.50 Mn
Jun 30, 2024 800,000.00
Jun 30, 2024 800,000.00
Mar 31, 2024 1.76 Mn
Mar 31, 2024 1.76 Mn
Dec 31, 2023 39.49 Mn
Dec 31, 2023 39.49 Mn
Sep 30, 2023 4.20 Mn
Sep 30, 2023 4.20 Mn
Jun 30, 2023 1.50 Mn
Jun 30, 2023 1.50 Mn
Mar 31, 2023 1.23 Mn
Mar 31, 2023 1.23 Mn
Dec 31, 2022 846,000.00
Dec 31, 2022 846,000.00
Sep 30, 2022 15.40 Mn
Sep 30, 2022 15.40 Mn
Jun 30, 2022 3.30 Mn
Jun 30, 2022 3.30 Mn
Mar 31, 2022 1.89 Mn
Mar 31, 2022 1.89 Mn
Dec 31, 2021 2.52 Mn
Dec 31, 2021 2.52 Mn
Sep 30, 2021 2.30 Mn
Sep 30, 2021 2.30 Mn
Jun 30, 2021 1.60 Mn
Jun 30, 2021 1.60 Mn
Mar 31, 2021 16.40 Mn
Mar 31, 2021 16.40 Mn
Jun 30, 2020 100,000.00
Jun 30, 2020 100,000.00
Dec 31, 2019 -4.17 Mn
Dec 31, 2019 -4.17 Mn
Sep 30, 2019 4.17 Mn
Sep 30, 2019 4.17 Mn
Jun 30, 2019 -4.17 Mn
Jun 30, 2019 -4.17 Mn
Mar 31, 2019 4.17 Mn
Mar 31, 2019 4.17 Mn
Dec 31, 2017 20.45 Mn
Dec 31, 2017 20.45 Mn
Dec 31, 2016 5.91 Mn
Dec 31, 2016 5.91 Mn
Dec 31, 2015 16.20 Mn
Dec 31, 2015 16.20 Mn
Dec 31, 2014 7.55 Mn
Dec 31, 2014 7.55 Mn
Dec 31, 2013 4.93 Mn
Dec 31, 2013 4.93 Mn
Dec 31, 2012 5.30 Mn
Dec 31, 2012 5.30 Mn
Dec 31, 2011 2.25 Mn
Dec 31, 2011 2.25 Mn
Dec 31, 2010 1.95 Mn
Dec 31, 2010 1.95 Mn